Cargando…

p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation

Limited information is available on the surface molecules that are involved in natural killer (NK) cell triggering. In this study, we selected the BAB281 monoclonal antibody (mAb) on the basis of its ability to trigger NK-mediated target cell lysis. BAB281 identified a novel NK cell–specific surface...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivori, Simona, Vitale, Massimo, Morelli, Luigia, Sanseverino, Lorenza, Augugliaro, Raffaella, Bottino, Cristina, Moretta, Lorenzo, Moretta, Alessandro
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211712/
https://www.ncbi.nlm.nih.gov/pubmed/9314561
_version_ 1782148543599869952
author Sivori, Simona
Vitale, Massimo
Morelli, Luigia
Sanseverino, Lorenza
Augugliaro, Raffaella
Bottino, Cristina
Moretta, Lorenzo
Moretta, Alessandro
author_facet Sivori, Simona
Vitale, Massimo
Morelli, Luigia
Sanseverino, Lorenza
Augugliaro, Raffaella
Bottino, Cristina
Moretta, Lorenzo
Moretta, Alessandro
author_sort Sivori, Simona
collection PubMed
description Limited information is available on the surface molecules that are involved in natural killer (NK) cell triggering. In this study, we selected the BAB281 monoclonal antibody (mAb) on the basis of its ability to trigger NK-mediated target cell lysis. BAB281 identified a novel NK cell–specific surface molecule of 46 kD (p46) that is expressed by all resting or activated NK cells. Importantly, unlike the NK cell antigens identified so far, the expression of p46 was strictly confined to NK cells. Upon mAb-mediated cross-linking, p46 molecules induced strong cell triggering leading to [Ca(2+)]i increases, lymphokine production, and cytolytic activity both in resting NK cells and NK cell clones. The p46-mediated induction of Ca(2+) increases or triggering of cytolytic activity was downregulated by the simultaneous engagement of inhibitory receptors including p58, p70, and CD94/NKG2A. Both the unique cellular distribution and functional capability of p46 molecules suggest a possible role in the mechanisms of non-major histocompatibility complex–restricted cytolysis mediated by human NK cells.
format Text
id pubmed-2211712
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22117122008-04-16 p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation Sivori, Simona Vitale, Massimo Morelli, Luigia Sanseverino, Lorenza Augugliaro, Raffaella Bottino, Cristina Moretta, Lorenzo Moretta, Alessandro J Exp Med Article Limited information is available on the surface molecules that are involved in natural killer (NK) cell triggering. In this study, we selected the BAB281 monoclonal antibody (mAb) on the basis of its ability to trigger NK-mediated target cell lysis. BAB281 identified a novel NK cell–specific surface molecule of 46 kD (p46) that is expressed by all resting or activated NK cells. Importantly, unlike the NK cell antigens identified so far, the expression of p46 was strictly confined to NK cells. Upon mAb-mediated cross-linking, p46 molecules induced strong cell triggering leading to [Ca(2+)]i increases, lymphokine production, and cytolytic activity both in resting NK cells and NK cell clones. The p46-mediated induction of Ca(2+) increases or triggering of cytolytic activity was downregulated by the simultaneous engagement of inhibitory receptors including p58, p70, and CD94/NKG2A. Both the unique cellular distribution and functional capability of p46 molecules suggest a possible role in the mechanisms of non-major histocompatibility complex–restricted cytolysis mediated by human NK cells. The Rockefeller University Press 1997-10-06 /pmc/articles/PMC2211712/ /pubmed/9314561 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Sivori, Simona
Vitale, Massimo
Morelli, Luigia
Sanseverino, Lorenza
Augugliaro, Raffaella
Bottino, Cristina
Moretta, Lorenzo
Moretta, Alessandro
p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
title p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
title_full p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
title_fullStr p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
title_full_unstemmed p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
title_short p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
title_sort p46, a novel natural killer cell–specific surface molecule that mediates cell activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211712/
https://www.ncbi.nlm.nih.gov/pubmed/9314561
work_keys_str_mv AT sivorisimona p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation
AT vitalemassimo p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation
AT morelliluigia p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation
AT sanseverinolorenza p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation
AT augugliaroraffaella p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation
AT bottinocristina p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation
AT morettalorenzo p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation
AT morettaalessandro p46anovelnaturalkillercellspecificsurfacemoleculethatmediatescellactivation